Displaying items by tag: adults
We’re looking for adults with ASCVD or high risk for ASCVD to join the V-INCLUSION Study, evaluating a new FDA-approved cholesterol-lowering injection called Inclisiran.
You may qualify if you:
✔️ Have a history of heart attack, stroke, TIA, or peripheral artery disease
✔️ Are currently taking a statin or have statin intolerance
✔️ Have high LDL-C (bad cholesterol)
✔️ Identify as female, live in a rural area, or are from an underrepresented racial or ethnic group
What’s in it for you?
✅ Free access to Inclisiran for at least one year
✅ Compensation provided for participation
✅ Extra monitoring and heart health screening in addition to your usual care
✅ Advance research that may improve heart health in underserved communities
? Half of participants will receive Inclisiran during Year 1, the other half in Year 2.
? Your participation may help shape better cardiovascular care for future generations.
?Spots are limited. Contact us today to see if you’re eligible!
Contact us at: 205-934-5217
Who's eligible for the study?
If you have been diagnosed with depression.
If you are between the ages of 18-64
If you are currently experiencing a major depressive episode that has lasted at least 3 weeks but not longer than 18 months.
If you are otherwise healthy and have not been diagnosed with other medically important conditions or psychiatric conditions such as bipolar disorder (BP), antisocial personality disorder (ASPD), obsessive compulsive disorder (OCD), borderline personality disorder (BPD) or attention-deficit/hyperactivity disorder (ADHD) or major diseases, have not had electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), deep brain stimulation or repetitive transcranial magnetic stimulation (TMS) within 5 years or have failed to respond to ECT at any time, This STUDY Might Be For You!
For more information, contact Dana Green at danagreen@uabmc.edu or 205-975-6426.
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples.
Participants will be compensated $675 for completing all the visits.
To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
The purpose of this NIH-funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This trial involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
- All visits to be completed within a three-month period.
Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All participants must be diagnosed with type 2 DM and not be on any type of insulin therapy.
Please contact Alaaeldin Hodhod at ahodhod@uabmc.edu or 205-996-9984 or Chanel Mason at 205-934-1921 or cnmason@uabmc.edu.
What’s Involved?
8 weekly intervention sessions (1 hour via Zoom)
Wearing a Fitbit to track sleep patterns (Fitbit provided)
Completing online sleep and quality of life surveys
Participating in a focus group at the end of the study
Who Can Participate?
Individuals aged 12 to 30 years old with a diagnosis of Down syndrome who experience sleep difficulties.
Compensation
Participants and caregivers can earn up to $400 for completing assessments and an additional $100 for participating in the focus group.
Flyer available here: https://uab.box.com/s/gxhs7htrb0270yrmgdv1hd4vubj1jhal
To sign up to study, complete this brief screening survey: https://uab.co1.qualtrics.com/jfe/form/SV_3HFdXpNJ96TEEDA?Q_CHL=qr
If you or someone you know may be interested reach out to Dr. Caroline G. Richter at carolinerichter@uab.edu or (205) 934-9897.
This study focuses on better understanding how diet influences quality of life in MPN patients. We will test whether an anti-inflammatory food regime can help alleviate symptoms and decelerate disease progression.
Participants will meet with study staff to collect non-invasive samples, undergo anthropometric and metabolic measurements, and answer study related questionnaires. Samples to be collected include blood and stool samples.
Participants will be compensated $50 for each visit and providing samples if simply continuing their regular food intake, or $90 each month if trying an anti-inflammatory food regime for 3 months and completing the study visits and providing samples. Participants who adhere to an anti-inflammatory regime and would like to continue a further 9 months may be eligible to continue participating with a compensation of $90 per month. Study participants in all groups would receive information related to body inflammation, vitamin D levels, and metabolism if desired.
Total maximum compensation of $150, $270 and $810 depending on study group.
For more information, please contact us via phone or email at:
Phone: 205-975-3752
Email addresses: tmarquezlago@uabmc.edu or mpn@uabmc.edu
-Study includes up to 16 in-person sessions of weekly counseling for free
-Remuneration in the form of up to two distributions of $10 and $15 for completing two surveys over the course of the study ($25 total)
To be included:
-You must be an adult (18 or older)
-Identify as LGBTQ+
Our study is a counseling intervention designed to address mental health concerns related to identity-related minority stress. However, there are a few conditions that we do not think would be a good fit. If you are experiencing severe drug addiction, past year history of suicide attempt/self-injury, eating disorder problems, or struggling with psychosis you would not be eligible for this study.
Please email Drew Whittington if interested in participating: whitdrew@uab.edu
The UAB STARS Lab is conducting a research study to explore children's motivation to complete moderately challenging tasks and how this relates to academic achievement, language, cognition, and behavior in individuals with Down syndrome.
Who can participate?
• Children aged 15-21 with a diagnosis of Down syndrome (both males and females are welcome).
What does the study involve?
• 1-2 days of activities at the University of Alabama at Birmingham in Campbell Hall.
• Your child will complete language and cognitive assessments, as well as game-like activities with a researcher.
• Caregivers will complete questionnaires and participate in an interview about their child’s communication, behavior, and development.
What will you receive?
• $50 compensation for participation.
• Reimbursement for travel expenses.
• A score report with your child’s results.
Learn more by contacting Dr. Caroline G. Richter at carolinerichter@uab.edu or (205) 934-9897.
You can learn more about our studies here: https://sites.uab.edu/richter/about/
To check eligibility, complete the screening survey at go.uab.edu/uab_qualtrics_ws_ds
Learn more about the CT-388-104 Study testing the safety and effectiveness of a selective GLP-1/GIP investigational drug for those living with overweight or obesity with type 2 diabetes.
You may be able to join the CT-388-104 Study if you:
- Are 18 through 75 years old
- Have a body mass index (BMI) of 25 or above
- Have been diagnosed with type 2 diabetes
- Have tried to lose weight once or more through diet and exercise but without success
There are other requirements for taking part in this study. The study team will go over these with you.
If you qualify to join, you may receive at no cost:
- The investigational drug or placebo
- Close medical care and follow-up throughout the study
- Lifestyle management counseling
Contact us to find out more about the CT-388-104 Study:
Alex Rolling, CRC, RD
alp0029@uab.edu
205-996-2689
The UAB Office of Psychiatric Research is actively recruiting participants for our studies and wants to connect with you on our research! Whether you are needing someone to talk to, or even have no history of mental health conditions and are just wanting to further knowledge within the medical and mental health field, we would love to get you involved!
Our studies can be broken down into two different categories:
1) TREATMENT STUDIES – Our Treatment Studies are designed to evaluate the effectiveness of new antidepressants on individuals living with Major Depressive Disorder or Treatment-Resistant Depression.
2) NON-TREATMENT STUDIES – Our Non-Treatment Studies do NOT involve testing a new medication or intervention. Instead, these studies focus on understanding behaviors and experiences of mental health conditions via interviews, tests, or surveys.
COMPENSATION IS PROVIDED!
For more information, please reach out to the UAB Office of Psychiatric Research at (205) 934-2484 or go to: https://tinyurl.com/UABpsychiatricresearch and our team will be in contact with you shortly!
Want to learn calligraphy?
Help us explore the effects of guided calligraphy training on mental health!
Check eligibility and sign up here: https://sites.uab.edu/calligraphyresearch
BENEFITS
Learn calligraphy with live instructor • Free online calligraphy training course • Free calligraphy supplies • Drawings for gift cards • Improve manual dexterity
PURPOSE
This is a pilot study to assess the feasibility of performing virtually administered art therapy research, as well as a preliminary study to explore whether calligraphy training affects anxiety levels in healthy individuals with mild to moderate anxiety.
TIME & LOCATION
All meetings and training sessions will be held on Zoom. Participation includes up to a total of 15 hours of time over 12 calendar weeks—an intro meeting, 4 training sessions, a debriefing meeting, and 15 minutes a day of practice--5 days a week for 4 weeks. Pending full recruitment, training classes will be held in January-February 2025.
HOW TO ENROLL
To learn more, check eligibility and sign up, click here: https://sites.uab.edu/calligraphyresearch
Interested in being part of vision rehabilitation research for healthy older adults aged 50-59 to lay the foundation of using a new device?
Here is an overview of what our study will involve!
The purpose of this study?
- Calculate baseline data for Bioness Integrated Therapy System (BITS) and identify its clinical implications in treating visual impairments.
- Compare the baseline data of Bioness Integrated Therapy System (BITS) to Dynavision for visual scanning.
Who are we looking for?
- Healthy adults aged 50-59 without physical, visual, or cognitive impairment and with no history of seizures or balance problems.
- Adults who are able to walk without assistive devices and are English speakers.
What would you have to do in 60 minutes?
- Fill out a short survey for demographic data.
- Quick functional screening of upper extremities.
- Perform four tests on BITS.
- Perform four tests on Dynavision.
Participants will receive a $25 gift card.
To participate in the study, please fill out this short survey:
https://uab.co1.qualtrics.com/jfe/form/SV_exEYGMKXxc230p0
For more information, please contact us at almulhim@uab.edu
If you are interested in seeing if you may qualify for an ongoing clinical study, please contact Christina Ndolo at cmndolo@uabmc.edu.
https://redcap.musc.edu/surveys/?s=8JWFT9XFY3FYR7Y3